These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30219473)

  • 21. Complementary medicine use in children and young adults with inflammatory bowel disease.
    Heuschkel R; Afzal N; Wuerth A; Zurakowski D; Leichtner A; Kemper K; Tolia V; Bousvaros A
    Am J Gastroenterol; 2002 Feb; 97(2):382-8. PubMed ID: 11866277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
    Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
    Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Disease.
    Phatak UP; Alper A; Pashankar DS
    J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):157-160. PubMed ID: 30499887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Complementary and Alternative Therapies in People with Inflammatory Bowel Disease.
    Frank L; Lambert K
    Int J Environ Res Public Health; 2024 Aug; 21(9):. PubMed ID: 39338023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experiences of complementary and alternative medicine in patients with inflammatory bowel disease - a qualitative study.
    Lindberg A; Fossum B; Karlen P; Oxelmark L
    BMC Complement Altern Med; 2014 Oct; 14():407. PubMed ID: 25338541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease].
    García-Planella E; Marín L; Domènech E; Bernal I; Mañosa M; Zabana Y; Gassull MA
    Med Clin (Barc); 2007 Jan; 128(2):45-8. PubMed ID: 17266900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway.
    Opheim R; Bernklev T; Fagermoen MS; Cvancarova M; Moum B
    Scand J Gastroenterol; 2012 Dec; 47(12):1436-47. PubMed ID: 23003678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practices and attitudes toward complementary and alternative medicine in inflammatory bowel disease: a survey of gastroenterologists.
    Gallinger ZR; Nguyen GC
    J Complement Integr Med; 2014 Dec; 11(4):297-303. PubMed ID: 25294717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Diseases: A Single-Center Survey.
    Serpico MR; Boyle BM; Kemper KJ; Kim SC
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):651-657. PubMed ID: 26960176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.
    Oxelmark L; Lindberg A; Löfberg R; Sternby B; Eriksson A; Almer S; Befrits R; Fossum B; Karlén P; Broström O; Tysk C;
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1320-8. PubMed ID: 27472271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.
    Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
    World J Gastroenterol; 2015 Mar; 21(12):3663-70. PubMed ID: 25834335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).
    Opheim R; Hoivik ML; Solberg IC; Moum B;
    J Crohns Colitis; 2012 Apr; 6(3):345-53. PubMed ID: 22405172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study.
    Koning M; Ailabouni R; Gearry RB; Frampton CM; Barclay ML
    Inflamm Bowel Dis; 2013; 19(4):767-78. PubMed ID: 23429459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey.
    Wong AP; Clark AL; Garnett EA; Acree M; Cohen SA; Ferry GD; Heyman MB
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):55-60. PubMed ID: 19172124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of complementary therapies by patients with IBD may indicate psychosocial distress.
    Langmead L; Chitnis M; Rampton DS
    Inflamm Bowel Dis; 2002 May; 8(3):174-9. PubMed ID: 11979137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A survey of perceptions and practices of complementary alternative medicine among Canadian gastroenterologists.
    Gallinger Z; Bressler B; Devlin SM; Plamondon S; Nguyen GC
    Can J Gastroenterol Hepatol; 2014 Jan; 28(1):45-9. PubMed ID: 24212913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complementary Therapies in Inflammatory Bowel Diseases.
    Yanai H; Salomon N; Lahat A
    Curr Gastroenterol Rep; 2016 Dec; 18(12):62. PubMed ID: 27747459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases.
    Kong SC; Hurlstone DP; Pocock CY; Walkington LA; Farquharson NR; Bramble MG; McAlindon ME; Sanders DS
    J Clin Gastroenterol; 2005 Feb; 39(2):138-41. PubMed ID: 15681910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD).
    Mousavi T; Nikfar S; Abdollahi M
    Expert Rev Clin Pharmacol; 2021 Jul; 14(7):865-888. PubMed ID: 33993811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.